of skin diseases
Researchers at the School of Medicine have demonstrated that Langerhans cells in the skin, which had been thought to alert the immune system to pathogens, instead dampen the skin's reaction to infection and inflammation.
This has the potential to significantly alter understanding of the mechanisms underlying many skin disorders such as psoriasis, lupus and skin cancer.
Dendritic cells are found throughout the body and are known to be extremely efficient at alerting the immune system to the presence of pathogens and other foreign materials. Langerhans cells are dendritic cells in the skin. Skin is an important barrier to infection, and scientists have generally assumed that the Langerhans cells only serve to warn the immune system of skin pathogens.
According to the study, featured on the cover of the Dec. 15 issue of Immunity, Langerhans cells are not required and, in fact, inhibit or modulate immune responses in the skin.
Dr. Daniel H. Kaplan and Dr. Mark J. Shlomchik used a technology called Bacterial Artificial Chromosome transgenics to develop a mouse model that lacks Langerhans cells in the skin from birth. The scientists stimulated the skin of these mice to create hypersensitivity similar to a poison ivy reaction. They expected that mice without Langerhans cells would have less immune response in the skin.
"Unexpectedly, instead of a decreased immune response to contact hypersensitivity, we found a reproducible and significant increase," says first author Kaplan, assistant professor in the Department of Dermatology. "Langerhans cells are thus not required to generate immune responses in the skin and more profoundly, they actually regulate immune responses in the skin."
According to senior author Shlomchik, professor of laboratory medicine and immunobiology, "We now have a new view of these cells, not just as sentinels or stimulators of immune reactions as previously thought, but more as peacekeepers with the environment, which poses a constant challenge to skin. Most such challenges are not dangerous and do not warrant an immune response."
Langerhans cells may function generally to prevent excessive responses in the skin. "Failure of this mechanism could result in chronic inflammatory skin conditions like lupus and psoriasis, says Shlomchik. "This is the new theory we would now like to test."
The findings could also have future implications for skin transplantation, autoimmune diseases and the immune system's ability to prevent skin cancer.
Other authors on the study included Mathew C. Jenison, Sem Saeland and Warren D. Shlomchik.
The study was funded by the National Institutes of Health through the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and the Dermatology Foundation.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Team finds genes that control aging
Q&A with President Richard C. Levin
Yale will study ways to promote tolerance via 'Difficult Dialogues' grant
ENDOWED PROFESSORSHIPSRecent alumna wins award for her Ph.D. dissertation
SCHOOL OF MEDICINE NEWS
Sequencing genome of bacteria that lives off fly may lead to . . .
Researchers' discovery about the role of particular cells may alter . . .
Study finds access is key to participation of minorities in research
Rate of chronic disability in older Americans is over-estimated . . .
New tool can help measure parents' role in child's pre-surgery anxietyMozart's 250th birthday bash begins Jan. 27
Recluse gets swept up in counter-terrorism
'Bread Upon the Waters' shows 'generosity' of Christian art
Tragic tale of 'The Duchess of Malfi' to unfold at Drama School
Conference examines the art of biography . . .
Two Yale scientists elected to American Physical Society
Spring architecture programs include talks by top designers
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home